Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Website URL
Similar Companies1000
Heat Biologics
Heat Biologics is a biopharmaceutical company focused on developing therapies to modulate the immune system.
Sector
Subsector
Location
total rounds
total raised
REGiMMUNE
REGiMMUNE is a biotech company producing immune-regulatory therapeutics for life-threatening diseases and debilitating disorders.
Sector
Subsector
Keywords
Location
total rounds
total raised
Orpheus Bioscience
Orpheus Bioscience develops novel treatments for autoimmune diseases.
Sector
Subsector
Location
Biond Biologics
Biond Biologics is an Israeli biotech company focused on cancer immunotherapy and autoimmune disorders.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 25.03.2024. Their latest investor Bristol Myers Squibb. Their latest round Venture - Series Unknown
OrbiMed
OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Acorn Bioventures
The company invests in and partners with biotech and medical device companies.
Sector
Subsector
Location
count Of Investments
Atlas Venture
Atlas Venture invests in biotech startups with seed and early stage venture investments.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Co-Investors
Investors13
Number of lead investors
Number of investors
Bristol Myers Squibb
Bristol-Myers Squibb is a pharmaceuticals and nutritional products company.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Atlas Venture
Atlas Venture invests in biotech startups with seed and early stage venture investments.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Acorn Bioventures
The company invests in and partners with biotech and medical device companies.
Sector
Subsector
Location
count Of Investments
People
Founders1
Shelia Violette
Shelia Violette, co-founder, Chief Scientific Officer, and President of Research of Q32 Bio, is a scientific leader in the field of inflammation, autoimmunity, and fibrosis. In her more than 20 years of industry experience advancing programs from early research to clinical development, Shelia has provided strategic and operational leadership to multi-disciplinary teams of scientists, led several research and early clinical programs, and authored more than 90 manuscripts and patents. Prior to co-founding Q32 Bio, she was an Entrepreneur in Residence at Atlas Venture and is an Adjunct Associate Professor in the Department of Internal Medicine at the Yale School of Medicine. Prior to her role at Atlas, Shelia served in leadership roles in the Immunology Research group at Biogen, joining Stromedix as Vice President of Research and returning to Biogen as Vice President of Research, spearheading the tissue injury and fibrosis therapeutic area. She also has directed research and led therapeutic programs at several biotechnology companies including Repligen and Ariad. She received her Ph.D. in Pharmacology from Yale University.
current job
organization founded
Shelia Violette
Employee Profiles7
Kathryn Golden
Head of Chemistry, Manufacturing, and Controls
Shelia Violette
Founder, Chief Scientific Officer, and President of Research
Activity
Recent News11
The graph reveals the ratio (%) of positive news articles in a chosen time range